Awarded
2022 NIAID Omnibus Broad Agency Announcement
Awarded tounder 75N93023C00055 (source: SAM.gov award notice)• $8.7M
Overview
- Posted
- September 26, 2023
- Notice type
- Award Notice
Notice details
- PSC
- AJ12: R&D- GENERAL SCIENCE/TECHNOLOGY: PHYSICAL SCIENCES (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
- Last updated
- Sep 9, 2025
- Award date
- Sep 25, 2023
- Award amount (SAM.gov award notice)
- $8.7M
Identifiers
- Solicitation number
- HHS-NIH-NIAID-BAA2022-1
- Notice ID
- 31e5b8db21984b608b51cc1437b94ce2
- Award number (PIID)
- 75N93023C00055
Description
This cost-reimbursement contract award was made under full and open competition. This type of contract was selected because costs cannot be adequately defined at the time of contract award. This contract is to advance the development of a broad-spectrum flavivirus mAb as a countermeasure against dengue by preparation and conduct of a Phase 2 dengue challenge clinical trial.
Award Overview
Award Number
75N93023C00055
Award Amount (SAM.gov award notice)
$8.7M
Award Date
Sep 25, 2023
Awardee
Awardee UEI
K3L6KXJ9B6M7
Original Solicitation
Notice ID: 31e5b8db21984b608b51cc1437b94ce2
Posted Date: Sep 26, 2023
Original Response Deadline: Not specified
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
HHS-NIH-NIAID-BAA2022-1- Pre-Solicitation
- Solicitation
- Awarded
This opportunity has been awarded.
- Pre-SolicitationJan 4, 2022
2022 NIAID Omnibus Broad Agency Announcement
- 5×SolicitationJan 18, 2022
2022 NIAID Omnibus Broad Agency Announcement
- 3×AwardedCurrentMay 1, 2023
2022 NIAID Omnibus Broad Agency Announcement
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
HHS-NIH-NIAID-BAA2022-1
Archive Date
Oct 10, 2023
Office Address
BETHESDA, MD, 20892